Support PenkeNovo Nordisk A/S - Trending symbols
Latest News of Novo Nordisk A/S
| Date | Title | Read |
|---|---|---|
| 2025-11-07 17:28 | Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call | Read |
| 2025-11-07 16:44 | LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs | Read |
| 2025-11-07 16:32 | Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus | Read |
| 2025-11-07 16:29 | Zepbound Maker Eli Lilly Stock Weighs In On Trump Weight-Loss Drug Deal | Read |
| 2025-11-07 16:25 | Novo Nordisk Sees Modest Sales Impact in 2026 After U.S. Drug Price Cuts | Read |
| 2025-11-06 23:30 | Trump inks Eli Lilly & Novo deals: How to play pharma stocks | Read |
| 2025-11-06 22:05 | Prothena Reports Third Quarter 2025 Financial Results and Business Highlights | Read |
| 2025-11-06 21:59 | Eli Lilly, Novo Nordisk to Cut Drug Prices, Get Tariff Relief Under Deals With Trump Administration | Read |
| 2025-11-06 21:02 | Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. | Read |
| 2025-11-06 20:30 | Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek® | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-11-07 |
Comments
How you think about this?